Noxopharm Ltd.ASX: NOX

New study further validates Noxopharms cancer pipeline

· Issued by Noxopharm Ltd. via ASX

Filed with ASX ·

Noxopharm Limited. ABN 50 608 966 123 Suite 71, 159 Ridgecrop Drive, Castle Hill, NSW 2154, Australia New study further validates Noxopharm’s cancer pipeline Highlights • Proof-of-principle that Noxopharm technology helps initiate immune response with normally ‘immune -...

View Attachment

6ix hasn’t read this filing yet.

Noxopharm Ltd. on 6ix

Story so far

Earlier from Noxopharm

Later from Noxopharm

All Noxopharm news releases